I

Immatics NV
D

IMTX

7.59000
USD
0.00
(0.00%)
مغلق
حجم التداول
0
الربح لكل سهم
0
العائد الربحي
-
P/E
-12
حجم السوق
922,564,925
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    AZN
    AZN
    -1.830
    (-2.81%)
    66.385 USD
    B
    BNTX
    -3.740
    (-3.61%)
    99.740 USD
    GSK
    GSK
    -1.020
    (-2.97%)
    33.350 USD
    JNJ
    JNJ
    2.140
    (1.41%)
    155.760 USD
    MRK
    MRK
    -2.050
    (-2.08%)
    101.205 USD
    MRNA
    MRNA
    -2.950
    (-7.42%)
    36.830 USD
    N
    NVAX
    0.12000
    (1.67%)
    7.32500 USD
    PFE
    PFE
    -1.225
    (-4.71%)
    26.160 USD
    REGN
    REGN
    -25.40
    (-3.25%)
    756.82 USD
    VRTX
    VRTX
    -18.53
    (-3.83%)
    462.07 USD
    المزيد
الأخبار

العنوان: Immatics NV

القطاع: Healthcare
الصناعة: Biotechnology
Immatics NV is a biotechnology company that is engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies.